129 related articles for article (PubMed ID: 1490073)
1. Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible.
Iversen PL; Crouse D; Zon G; Perry G
Antisense Res Dev; 1992; 2(3):223-33. PubMed ID: 1490073
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 rev antisense phosphorothioate oligonucleotide binding to human mononuclear cells is cell type specific and inducible.
Pirruccello SJ; Perry GA; Bock PJ; Lang MS; Noel SM; Zon G; Iversen PL
Antisense Res Dev; 1994; 4(4):285-9. PubMed ID: 7734943
[TBL] [Abstract][Full Text] [Related]
3. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible.
Krieg AM; Gmelig-Meyling F; Gourley MF; Kisch WJ; Chrisey LA; Steinberg AD
Antisense Res Dev; 1991; 1(2):161-71. PubMed ID: 1841658
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells.
Iversen PL; Zhu S; Meyer A; Zon G
Antisense Res Dev; 1992; 2(3):211-22. PubMed ID: 1490072
[TBL] [Abstract][Full Text] [Related]
6. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
Zelphati O; Zon G; Leserman L
Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
[TBL] [Abstract][Full Text] [Related]
8. Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner.
Mojcik CF; Gourley MF; Klinman DM; Krieg AM; Gmelig-Meyling F; Steinberg AD
Clin Immunol Immunopathol; 1993 May; 67(2):130-6. PubMed ID: 7686091
[TBL] [Abstract][Full Text] [Related]
9. A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation.
McIntyre KW; Lombard-Gillooly K; Perez JR; Kunsch C; Sarmiento UM; Larigan JD; Landreth KT; Narayanan R
Antisense Res Dev; 1993; 3(4):309-22. PubMed ID: 8155973
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors.
Zhao Q; Waldschmidt T; Fisher E; Herrera CJ; Krieg AM
Blood; 1994 Dec; 84(11):3660-6. PubMed ID: 7949121
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation.
Zhao Q; Song X; Waldschmidt T; Fisher E; Krieg AM
Blood; 1996 Sep; 88(5):1788-95. PubMed ID: 8781436
[TBL] [Abstract][Full Text] [Related]
12. Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications.
McKay RA; Cummins LL; Graham MJ; Lesnik EA; Owens SR; Winniman M; Dean NM
Nucleic Acids Res; 1996 Feb; 24(3):411-7. PubMed ID: 8602351
[TBL] [Abstract][Full Text] [Related]
13. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice.
Zhao Q; Zhou R; Temsamani J; Zhang Z; Roskey A; Agrawal S
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):451-8. PubMed ID: 9918109
[TBL] [Abstract][Full Text] [Related]
14. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.
Branda RF; Moore AL; Mathews L; McCormack JJ; Zon G
Biochem Pharmacol; 1993 May; 45(10):2037-43. PubMed ID: 8512586
[TBL] [Abstract][Full Text] [Related]
15. Amplification of antibody production by phosphorothioate oligodeoxynucleotides.
Branda RF; Moore AL; Lafayette AR; Mathews L; Hong R; Zon G; Brown T; McCormack JJ
J Lab Clin Med; 1996 Sep; 128(3):329-38. PubMed ID: 8783641
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of glucocorticoid-dependent apoptosis in murine lymphoid subpopulations in vivo following coexposure to lipopolysaccharide and vomitoxin (deoxynivalenol).
Islam Z; King LE; Fraker PJ; Pestka JJ
Toxicol Appl Pharmacol; 2003 Mar; 187(2):69-79. PubMed ID: 12649039
[TBL] [Abstract][Full Text] [Related]
17. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.
Hartmann G; Krug A; Waller-Fontaine K; Endres S
Mol Med; 1996 Jul; 2(4):429-38. PubMed ID: 8827713
[TBL] [Abstract][Full Text] [Related]
18. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
Ermak TH; Steger HJ; Wofsy D
Lab Invest; 1989 Oct; 61(4):447-56. PubMed ID: 2529396
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
20. Effect of different chemically modified oligodeoxynucleotides on immune stimulation.
Zhao Q; Temsamani J; Iadarola PL; Jiang Z; Agrawal S
Biochem Pharmacol; 1996 Jan; 51(2):173-82. PubMed ID: 8615886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
